MedTrace Logo

PROstate CAncer Radiotherapy - Bowel Quality of Life (PROCAR-BQ)

NCT05880446 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2024-05-13

No results posted yet for this study

Summary

This is a prospective pilot study to evaluate the mean increase of bowel symptoms after pelvic radiotherapy (RT) in prostate cancer (PCa) patient using the validated \& newly translated EORTC-QLQ PRT20 module.

Conditions

  • Prostate Cancer
  • Radiotherapy Side Effect
  • Bowel Dysfunction
  • Quality of Life

Interventions

OTHER

Bowel symptoms & QoL assessment

QoL and bowel symptoms questionnaires will be held to patients, anthropomorphic measurement, handgrip test, physical activity level and usual diet quality of the patient will be assessed.

Sponsors & Collaborators

  • Jules Bordet Institute

    lead OTHER

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-06
Primary Completion
2024-03-29
Completion
2024-03-29

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05880446 on ClinicalTrials.gov